These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Ehrnborg C, Ellegård L, Bosaeus I, Bengtsson BA, Rosén T. Clin Endocrinol (Oxf); 2005 Apr; 62(4):449-57. PubMed ID: 15807876 [Abstract] [Full Text] [Related]
26. Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women. Toth MJ, Sites CK, Matthews DE, Casson PR. Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E483-90. PubMed ID: 16621894 [Abstract] [Full Text] [Related]
27. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E92-101. PubMed ID: 14506079 [Abstract] [Full Text] [Related]
28. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. Albert SG, Haas MJ, Mooradian AD. Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687 [Abstract] [Full Text] [Related]
29. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Gravholt CH, Hjerrild BE, Naeraa RW, Engbaek F, Mosekilde L, Christiansen JS. Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835 [Abstract] [Full Text] [Related]
30. Growth hormone and body composition in athletes. Frisch H. J Endocrinol Invest; 1999 May; 22(5 Suppl):106-9. PubMed ID: 10442579 [Abstract] [Full Text] [Related]
31. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. Yuen KC, Dunger DB. Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975 [Abstract] [Full Text] [Related]
32. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting. Esposito JG, Thomas SG, Kingdon L, Ezzat S. Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E494-503. PubMed ID: 15886228 [Abstract] [Full Text] [Related]
33. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness. Gleeson HK, Shalet SM. Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466 [Abstract] [Full Text] [Related]
34. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients. Höybye C, Hilding A, Marcus C, Thorén M. Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042 [Abstract] [Full Text] [Related]
36. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Garcia JM, Polvino WJ. Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529 [Abstract] [Full Text] [Related]
37. The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. Giannoulis MG, Jackson N, Shojaee-Moradie F, Nair KS, Sonksen PH, Martin FC, Umpleby AM. J Clin Endocrinol Metab; 2008 Aug; 93(8):3066-74. PubMed ID: 18477661 [Abstract] [Full Text] [Related]
38. Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGH. Aperghis M, Velloso CP, Hameed M, Brothwood T, Bradley L, Bouloux PM, Harridge SD, Goldspink G. Growth Horm IGF Res; 2009 Feb; 19(1):61-7. PubMed ID: 18799338 [Abstract] [Full Text] [Related]
39. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ. Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [Abstract] [Full Text] [Related]
40. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]